SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001104659-21-057644
Filing Date
2021-04-29
Accepted
2021-04-29 16:27:07
Documents
5
Effectiveness Date
2021-04-29

Document Format Files

Seq Description Document Type Size
1 FORM S-8 tm2114385d1_s8.htm S-8 67253
2 EXHIBIT 5.1 tm2114385d1_ex5-1.htm EX-5.1 13996
3 EXHIBIT 23.1 tm2114385d1_ex23-1.htm EX-23.1 2487
4 GRAPHIC image_001.jpg GRAPHIC 3099
5 GRAPHIC tm2114385d1_ex5-1image002.jpg GRAPHIC 3099
  Complete submission text file 0001104659-21-057644.txt   93593
Mailing Address 863 MITTEN ROAD SUITE 102 BURLINGAME CA 94010
Business Address 863 MITTEN ROAD SUITE 102 BURLINGAME CA 94010 (650) 900-4520
Corvus Pharmaceuticals, Inc. (Filer) CIK: 0001626971 (see all company filings)

IRS No.: 464670809 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-255614 | Film No.: 21871095
SIC: 2834 Pharmaceutical Preparations